News
The expectations that companies deal with sustainability risks are increasing. The pressure is also growing in the pharmaceutical industry. At first glance, the highly regulated industry does not need to worry too much in the so-called ESG area. However, controversies are looming, especially when it comes to social criteria.
Von Eugenie Ankowitsch
Experts try to predict the economic costs of the lockdown in China. Affected municipalities have to bear high costs and suffer from production cutbacks. Zero Covid is also a logistical nightmare. And problems in the transport sector further exacerbate the situation.
Von Christiane Kuehl